Literature DB >> 24192596

Routine HIV screening in North Carolina in the era of the Affordable Care Act: update on laws, reimbursement, and tests.

Becky L White1, Yvonne L Carter, Katherine Records, Ian B K Martin.   

Abstract

Eighteen percent of the 1.2 million human immunodeficiency virus (HIV)-infected individuals in the United States are undiagnosed, with North Carolina accounting for the eighth largest number of new HIV diagnoses in 2011. In an effort to identify more HIV-infected individuals by reducing physician barriers to HIV testing, the Centers for Disease Control and Prevention have expanded their HIV screening recommendations to adolescents and adults without HIV risk factors or behaviors, eliminated federal requirements for pretest counseling, and modified the informed consent process. In 2010, the Office of National AIDS (acquired immunodeficiency syndrome) Policy released the first-ever national HIV/AIDS strategy, with the goal of reducing new infections, increasing access to care, improving HIV outcomes, and reducing HIV racial/ethnic disparities. In 2013, the US Preventive Services Task Force released A-level recommendations recommending nonrisk-based HIV screening for adults and adolescents that are consistent with the recommendations of the Centers for Disease Control and Prevention. In concert with these federal recommendations, the majority of states have modified their consent and counseling requirements. The implementation of the Patient Protection and Affordable Care Act will add requirements and incentives for federal (Medicare), state (Medicaid), and private (insurance) payers to reimburse physicians and patients for nonrisk-based HIV screening.

Entities:  

Mesh:

Year:  2013        PMID: 24192596      PMCID: PMC3842190          DOI: 10.1097/SMJ.0000000000000017

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  22 in total

1.  HIV surveillance--United States, 1981-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-06-03       Impact factor: 17.586

2.  Detection of acute HIV infection: we can't close the window.

Authors:  Bernard M Branson; Joanne D Stekler
Journal:  J Infect Dis       Date:  2011-12-29       Impact factor: 5.226

3.  Centers for Disease Control and Prevention 2006 human immunodeficiency virus testing recommendations and state testing laws.

Authors:  Sarah Neff; Ronald Goldschmidt
Journal:  JAMA       Date:  2011-05-04       Impact factor: 56.272

Review 4.  Contextual factors and the black-white disparity in heterosexual HIV transmission.

Authors:  Adaora A Adimora; Victor J Schoenbach
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

5.  HIV/AIDS: the state of the epidemic after 3 decades.

Authors:  Jennifer Kates; Alicia Carbaugh; David Rousseau; Anne Jankiewicz
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

6.  The future of HIV prevention in the United States.

Authors:  Jonathan Mermin; Kevin A Fenton
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

Review 7.  Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.

Authors:  Roger Chou; Shelley Selph; Tracy Dana; Christina Bougatsos; Bernadette Zakher; Ian Blazina; P Todd Korthuis
Journal:  Ann Intern Med       Date:  2012-11-20       Impact factor: 25.391

Review 8.  Adolescents and HIV infection: the pediatrician's role in promoting routine testing.

Authors:  Patricia J Emmanuel; Jaime Martinez
Journal:  Pediatrics       Date:  2011-10-31       Impact factor: 7.124

9.  Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

10.  Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2013-07-02       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.